TrueBinding
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4701 Patrick Henry Dr Ste 2101, Santa Cl...Phone Number
(650) 847-1117Website
www.truebinding.comRevenue
$8.5 MillionIndustry
About TrueBinding
Founded in 2016, TrueBinding Inc. is a clinical stage biotherapeutic company focused on developing innovative molecules for treating neurodegenerative diseases, stroke, metabolic diseases, oncology, and other areas with significant unmet medical needs. The company is advancing its investigational drug TB006, which targets Galectin-3 to address chronic inflammation and is currently available through an FDA-authorized Expanded Access Program for patients with serious conditions like Alzheimer's disease. TrueBinding aims to provide immediate treatment options while continuing clinical trials to establish the safety and efficacy of its products. Their research emphasizes the importance of addressing neurodegeneration as a critical challenge in extending healthspan.Explore more
TrueBinding Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to TrueBinding
Compare insights from companies similar to TrueBinding, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$132.7M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
TrueBinding Tech Stack
A closer look at the technologies used by TrueBinding
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding TrueBinding
Sign Up For FreeTo access detailed company insights
Founded in 2016, TrueBinding Inc. is a clinical stage biotherapeutic company focused on developing innovative molecules for treating neurodegenerative diseases, stroke, metabolic diseases, oncology, and other areas with significant unmet medical needs. The company is advancing its investigational drug TB006, which targets Galectin-3 to address chro... Read More
